Galderma Group AG
202.20
EUR
+12.75
(+6.73%)
Important Dates
Galderma Group AG's next confirmed earnings release is scheduled for March 11, 2027.
| Earnings Date | 3/11/2027 |
Share Statistics
As of December 31, 2025, Galderma Group AG has 234.57M shares outstanding.
| Shares Outstanding | 234.57M |
Financial Position
As of December 31, 2025, Galderma Group AG maintains a current ratio of 1.19, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.19 |
| Quick Ratio | 0.38 |
| Debt / Equity | 33.80 |
Financial Efficiency
These figures cover the twelve months ended December 31, 2025.
| Employee Count | 7,110.50 |
Stock Price Statistics
EURThese figures are as of the close on October 22, 2026.
| 50-Day Moving Average | 176.60 |
Balance Sheet
EURAs of December 31, 2025, Galderma Group AG holds 663.86M in cash and equivalents against 2.34B in total debt, resulting in a net debt position of 1.55B. Total book value stands at 6.94B, with working capital of 325.12M providing operational flexibility.
| Cash & Cash Equivalents | 663.86M |
| Total Debt | 2.34B |
| Net Debt | 1.55B |
| Equity (Book Value) | 6.94B |
| Book Value Per Share | 29.57 |
| Working Capital | 325.12M |